$7.06
1.26% today
Nasdaq, Feb 28, 04:39 pm CET
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Stock price

$7.15
+0.21 3.03% 1M
-1.87 20.73% 6M
-0.36 4.79% YTD
-1.17 14.06% 1Y
-3.54 33.12% 3Y
-7.34 50.66% 5Y
-3.04 29.80% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.18 2.46%
ISIN
CA74319B5027
Symbol
PROF
Sector

Key metrics

Market capitalization $214.70m
Enterprise Value $193.81m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 21.58
P/S ratio (TTM) P/S ratio 23.91
P/B ratio (TTM) P/B ratio 5.68
Revenue growth (TTM) Revenue growth 39.35%
Revenue (TTM) Revenue $8.98m
EBIT (operating result TTM) EBIT $-33.09m
Free Cash Flow (TTM) Free Cash Flow $-24.49m
Cash position $27.12m
EPS (TTM) EPS $-1.34
P/E forward negative
P/S forward 19.13
EV/Sales forward 17.27
Short interest 2.71%
Show more

Is Profound Medical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Profound Medical Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Profound Medical Corp forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Profound Medical Corp forecast:

Buy
100%

Financial data from Profound Medical Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
8.98 8.98
39% 39%
100%
- Direct Costs 3.41 3.41
33% 33%
38%
5.57 5.57
44% 44%
62%
- Selling and Administrative Expenses 21 21
38% 38%
237%
- Research and Development Expense 16 16
20% 20%
181%
-32 -32
28% 28%
-356%
- Depreciation and Amortization 1.16 1.16
5% 5%
13%
EBIT (Operating Income) EBIT -33 -33
27% 27%
-368%
Net Profit -31 -31
8% 8%
-350%

In millions USD.

Don't miss a Thing! We will send you all news about Profound Medical Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Profound Medical Corp Stock News

Neutral
GlobeNewsWire
15 days ago
TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025.
Neutral
GlobeNewsWire
about 2 months ago
– Fourth quarter revenue growth estimated at 105% to 110% year-over-year – – Company to start reporting in accordance with U.S. GAAP and filing with the SEC on U.S. domestic forms – – Profound reminds investors that it is scheduled to present at JPM 2025 on January 16 th at 11:15 a.m. PT – TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or th...
Neutral
GlobeNewsWire
about 2 months ago
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company's business at the 43rd Annual J.P. Morgan Healthcare Conference ...
More Profound Medical Corp News

Company Profile

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Head office Canada
CEO Arun Menawat
Employees 131
Founded 2008
Website www.profoundmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today